Jeremy Murray

5.1k total citations
36 papers, 1.8k citations indexed

About

Jeremy Murray is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jeremy Murray has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Jeremy Murray's work include Ubiquitin and proteasome pathways (7 papers), Microbial metabolism and enzyme function (6 papers) and Cancer-related Molecular Pathways (6 papers). Jeremy Murray is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Microbial metabolism and enzyme function (6 papers) and Cancer-related Molecular Pathways (6 papers). Jeremy Murray collaborates with scholars based in United States, United Kingdom and Switzerland. Jeremy Murray's co-authors include Ingrid E. Wertz, Dirksen E. Bussiere, Wendy Sandoval, Carrie M. Wilmot, Simon E. V. Phillips, Michael J. McPherson, Peter F. Knowles, Wayne J. Fairbrother, Markus Wartmann and Vito Guagnano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Jeremy Murray

36 papers receiving 1.8k citations

Peers

Jeremy Murray

ONCOL

BIOCH

Roland K. Chiu Netherlands

Melissa M. Dix United States

Rob Oslund United States

Nachiket Vartak Germany

K. Huber United Kingdom

Naoaki Fujii United States

Hideo Ogiso Japan

Urs Regenass Switzerland

Raymond E. Moellering United States

Gillian Paine-Murrieta United States

Roland K. Chiu Netherlands

Jeremy Murray

872 ×0.6

284 ×0.9

ONCOL

256 ×0.9

108 ×0.5

60 ×0.4

BIOCH

Citations per year, relative to Jeremy Murray Jeremy Murray (= 1×) peers Roland K. Chiu

Countries citing papers authored by Jeremy Murray

Since Specialization

Citations

This map shows the geographic impact of Jeremy Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Murray more than expected).

Fields of papers citing papers by Jeremy Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Murray. The network helps show where Jeremy Murray may publish in the future.

Co-authorship network of co-authors of Jeremy Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Murray. A scholar is included among the top collaborators of Jeremy Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Murray. Jeremy Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wertz, Ingrid E. & Jeremy Murray. (2019). Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms. Drug Discovery Today Technologies. 31. 109–123. 44 indexed citations

Safina, Brian S., Richard L. Elliott, Andrew K. Forrest, et al.. (2017). Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles. ACS Medicinal Chemistry Letters. 8(9). 936–940. 22 indexed citations

Lello, Paola Di, Richard Pastor, Jeremy Murray, et al.. (2017). Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques. Journal of Medicinal Chemistry. 60(24). 10056–10070. 65 indexed citations

Smith, Aaron, Zhi‐Jie Ni, Daniel Poon, et al.. (2017). Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(23). 5221–5224. 8 indexed citations

Almagro, M. Cristina de, Tatiana Goncharov, Anita Izrael-Tomasevic, et al.. (2016). Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death. Cell Death and Differentiation. 24(1). 26–37. 95 indexed citations

Rougé, Lionel, Travis W. Bainbridge, Michael C. M. Kwok, et al.. (2016). Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation. Structure. 24(8). 1335–1345. 80 indexed citations

Hu, Huiyong, Xiaojing Wang, Jae H. Chang, et al.. (2015). Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(22). 5258–5264. 19 indexed citations

Noland, Cameron L., Sarah Gierke, Paul D. Schnier, et al.. (2015). Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling. Structure. 24(1). 179–186. 188 indexed citations

Murray, Jeremy, Anthony M. Giannetti, Micah Steffek, et al.. (2013). Tailoring Small Molecules for an Allosteric Site on Procaspase‐6. ChemMedChem. 9(1). 73–77. 24 indexed citations

10.

Wang, Xiaojing, Steven Magnuson, Huiyong Hu, et al.. (2013). Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Bioorganic & Medicinal Chemistry Letters. 23(11). 3149–3153. 55 indexed citations

11.

Murray, Jeremy & Adam R. Renslo. (2013). Modulating caspase activity: beyond the active site. Current Opinion in Structural Biology. 23(6). 812–819. 15 indexed citations

12.

Safina, Brian S., Zachary K. Sweeney, Jun Li, et al.. (2013). Identification of GNE-293, a potent and selective PI3Kδ inhibitor: Navigating in vitro genotoxicity while improving potency and selectivity. Bioorganic & Medicinal Chemistry Letters. 23(17). 4953–4959. 25 indexed citations

13.

Mukund, Susmith, Holly J. Clarke, Azadeh Madjidi, et al.. (2013). Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor. Journal of Biological Chemistry. 288(50). 36168–36178. 33 indexed citations

14.

Katschke, Kenneth J., Ping Wu, Rajkumar Ganesan, et al.. (2012). Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite. Journal of Biological Chemistry. 287(16). 12886–12892. 66 indexed citations

15.

Zobel, Kerry, Herman Gill, Annie Ogasawara, et al.. (2011). The Development of Peptide-Based Tools for the Analysis of Angiogenesis. Chemistry & Biology. 18(7). 839–845. 34 indexed citations

16.

Murray, Jeremy & Dirksen E. Bussiere. (2009). Targeting the Purinome. Methods in molecular biology. 575. 47–92. 19 indexed citations

17.

Knapp, Mark, Cornelia Bellamacina, Jeremy Murray, & Dirksen E. Bussiere. (2006). Targeting Cancer: The Challenges and Successes of Structure-Based Drug Design Against the Human Purinome. Current Topics in Medicinal Chemistry. 6(11). 1129–1159. 13 indexed citations

18.

Lin, Xiaodong, Jeremy Murray, Michael Wang, et al.. (2006). Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies. Bioorganic & Medicinal Chemistry Letters. 16(16). 4163–4168. 30 indexed citations

19.

Murray, Jeremy, et al.. (2002). Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogue. Biochemical Journal. 365(3). 809–816. 18 indexed citations

20.

Murray, Jeremy, Carrie M. Wilmot, Joachim Jaeger, et al.. (1999). The Active Site Base Controls Cofactor Reactivity inEscherichia coliAmine Oxidase: X-ray Crystallographic Studies with Mutational Variants^,. Biochemistry. 38(26). 8217–8227. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact